Life Sciences — Operating profit
Danaher Life Sciences — Operating profit increased by 192.9% to $222.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 534.3%, from $35.00M to $222.00M. Over 2 years (FY 2021 to FY 2024), Life Sciences — Operating profit shows a downward trend with a -55.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates improved operational efficiency, better pricing power, or higher demand for life science products, while a decrease may signal rising costs, competitive pressure, or integration challenges from recent acquisitions.
Detailed definition
This metric represents the operating income generated by the Life Sciences business segment, calculated as segment reven...
Peer comparison
Comparable to segment-level operating income reported by peers in the life sciences and diagnostics industry, though variations exist based on how companies allocate corporate overhead and R&D expenses.
dhr_segment_life_sciences_operating_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.14B | $975.00M | $1.10B | $1.12B | $1.17B | $1.05B | $321.00M | $340.00M | $313.00M | $235.00M | $235.00M | $233.00M | $35.00M | $376.00M | $201.00M | -$239.00M | $222.00M |
| QoQ Change | — | -14.8% | +12.5% | +1.9% | +5.0% | -11.0% | -69.3% | +5.9% | -7.9% | -24.9% | +0.0% | -0.9% | -85.0% | +974.3% | -46.5% | -218.9% | +192.9% |
| YoY Change | — | — | — | — | +2.6% | +7.2% | -71.3% | -71.0% | -70.0% | — | -26.8% | -31.5% | -88.8% | +60.0% | -14.5% | -202.6% | +534.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — operating profit?
- Danaher (DHR) reported life sciences — operating profit of $222.00M in Q3 2025.
- How has Danaher's life sciences — operating profit changed year-over-year?
- Danaher's life sciences — operating profit increased by 534.3% year-over-year, from $35.00M to $222.00M.
- What is the long-term trend for Danaher's life sciences — operating profit?
- Over 2 years (2021 to 2024), Danaher's life sciences — operating profit has grown at a -55.1% compound annual growth rate (CAGR), from $4.37B to $879.00M.
- What does life sciences — operating profit mean?
- The core profit earned by the Life Sciences business segment after accounting for all direct operating expenses.